Repurposing Bromocriptine for Abeta Metabolism in Alzheimer's Disease
Condition: Alzheimer's Disease With PSEN1 Mutations Interventions: Drug: Bromocriptine; Drug: Placebos Sponsors: Kyoto University; Mie University; Osaka University; Tokushima University; Tokyo Metropolitan Geriatric Medical Center; Asakayama General Hospital; Kawasaki Medical School Hospital; Time Therapeutics, Inc.; Towa Pharmaceutical Co.,Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials